125 related articles for article (PubMed ID: 29479141)
1. Minimal change disease of the kidney in a young Sprague Dawley rat.
Yasuno K; Honda K; Hakamata S; Kai K; Mori K
J Toxicol Pathol; 2018 Jan; 31(1):55-59. PubMed ID: 29479141
[TBL] [Abstract][Full Text] [Related]
2. Temporal and spatial expression of podocyte-associated molecules are accompanied by proteinuria in IgA nephropathy rat model.
Lu H; Chen LL; Jiang XY; Mo Y; Ling YH; Sun LZ
Physiol Res; 2013; 62(1):35-45. PubMed ID: 23173680
[TBL] [Abstract][Full Text] [Related]
3. Early-onset podocyte injury and glomerular sclerosis in osborne-mendel rats.
Yasuno K; Ishihara S; Saito R; Ishikawa M; Kato T; Kobayashi R; Baba T; Kawano K; Ogihara K; Kamiie J; Shirota K
J Vet Med Sci; 2010 Oct; 72(10):1319-27. PubMed ID: 20495300
[TBL] [Abstract][Full Text] [Related]
4. [Relationship between podocyte molecule's distribution and expression, foot process morphology and proteinuria].
Guan N; Deng JH; Ding J; Zhang JJ; Yang JY
Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Apr; 36(2):139-44. PubMed ID: 15100730
[TBL] [Abstract][Full Text] [Related]
5. Punctate IgG staining particles localize in the budding ballooning clusters of reactive foot processes in minimal change disease.
Zhang PL; Mahalingam VD; Metcalf BD; Al-Othman YA; Li W; Kanaan HD; Herrera GA
Ultrastruct Pathol; 2024 Mar; 48(2):121-127. PubMed ID: 38098281
[TBL] [Abstract][Full Text] [Related]
6. Similar Biophysical Abnormalities in Glomeruli and Podocytes from Two Distinct Models.
Embry AE; Liu Z; Henderson JM; Byfield FJ; Liu L; Yoon J; Wu Z; Cruz K; Moradi S; Gillombardo CB; Hussain RZ; Doelger R; Stuve O; Chang AN; Janmey PA; Bruggeman LA; Miller RT
J Am Soc Nephrol; 2018 May; 29(5):1501-1512. PubMed ID: 29572404
[No Abstract] [Full Text] [Related]
7. β1-Integrin blockade prevents podocyte injury in experimental models of minimal change disease.
Cara-Fuentes G; Verma R; Venkatareddy M; Bauer C; Piani F; Aksoy ST; Vazzalwar N; Garcia GE; Banks M; Ordoñez FA; de Lucas-Collantes C; Bjornstad P; González Rodríguez JD; Johnson RJ; Garg P
Nefrologia (Engl Ed); 2024; 44(1):90-99. PubMed ID: 37150673
[TBL] [Abstract][Full Text] [Related]
8. Novel role of Vav1-Rac1 pathway in actin cytoskeleton regulation in interleukin-13-induced minimal change-like nephropathy.
Chan CY; Ng KH; Chen J; Lu J; Lee CG; Tan PH; Jordan SC; He HY; Yap HK
Clin Sci (Lond); 2016 Dec; 130(24):2317-2327. PubMed ID: 27707912
[TBL] [Abstract][Full Text] [Related]
9. Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis.
Shirato I; Sakai T; Kimura K; Tomino Y; Kriz W
Am J Pathol; 1996 Apr; 148(4):1283-96. PubMed ID: 8644869
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
Wang S; Li Y; Zhao J; Zhang J; Huang Y
Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
[TBL] [Abstract][Full Text] [Related]
11. Emodin ameliorates high glucose induced-podocyte epithelial-mesenchymal transition in-vitro and in-vivo.
Chen T; Zheng LY; Xiao W; Gui D; Wang X; Wang N
Cell Physiol Biochem; 2015; 35(4):1425-36. PubMed ID: 25791065
[TBL] [Abstract][Full Text] [Related]
12. Bi-nucleation of podocytes is uniformly accompanied by foot processes widening in renal disease.
Mühldorfer J; Pfister E; Büttner-Herold M; Klewer M; Amann K; Daniel C
Nephrol Dial Transplant; 2018 May; 33(5):796-803. PubMed ID: 29106627
[TBL] [Abstract][Full Text] [Related]
13. A Review of Podocyte Biology.
Garg P
Am J Nephrol; 2018; 47 Suppl 1():3-13. PubMed ID: 29852492
[TBL] [Abstract][Full Text] [Related]
14. [Effect of bone morphogenic protein 7 on nephrin expression and distribution in diabetic rat kidneys].
Xiao HQ; Shi W; Zhang Y; Liang YZ
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Apr; 29(4):671-5. PubMed ID: 19403392
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural study on nephrin expression in experimental puromycin aminonucleoside nephrosis.
Lee YK; Kwon T; Kim DJ; Huh W; Kim YG; Oh HY; Kawachi H
Nephrol Dial Transplant; 2004 Dec; 19(12):2981-6. PubMed ID: 15385636
[TBL] [Abstract][Full Text] [Related]
16. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
17. Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome.
Wernerson A; Dunér F; Pettersson E; Widholm SM; Berg U; Ruotsalainen V; Tryggvason K; Hultenby K; Söderberg M
Nephrol Dial Transplant; 2003 Jan; 18(1):70-6. PubMed ID: 12480962
[TBL] [Abstract][Full Text] [Related]
18. Rho-kinase inhibition prevents proteinuria in immune-complex-mediated antipodocyte nephritis.
Meyer-Schwesinger C; Dehde S; Sachs M; Mathey S; Arefi K; Gatzemeier S; Balabanov S; Becker JU; Thaiss F; Meyer TN
Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1015-25. PubMed ID: 22811486
[TBL] [Abstract][Full Text] [Related]
19. Glomeruli from patients with nephrin mutations show increased number of ciliated and poorly differentiated podocytes.
Vukojevic K; Raguz F; Saraga M; Filipovic N; Bocina I; Kero D; Glavina Durdov M; Martinovic V; Saraga-Babic M
Acta Histochem; 2018 Nov; 120(8):748-756. PubMed ID: 30193978
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of podocyte injury in malignant hypertensive nephropathy of rats (MSHRSP/Kpo strain).
Kato T; Mizuguchi N; Ito A
Biomed Res; 2015; 36(5):313-21. PubMed ID: 26522148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
